What is the Guardant Health Inc. stock price forecast?

Guardant Health Inc. is currently trading at $127.34. View real-time AI analysis on Alpha Lenz.

What is Guardant Health Inc. insider trading activity?

View the latest insider trading data for Guardant Health Inc. on Alpha Lenz.

What is Guardant Health Inc.'s P/E ratio?

Guardant Health Inc.'s P/E ratio is -38.4.

Guardant Health Inc.

NASDAQ · GH

$127.34-2.48(-1.91%)Pre-market

Ask about Guardant Health Inc.'s future dividend policy...

Alpha Chat Insight

“Guardant Health Inc. trades at a P/E of -38.4 (undervalued) with strong ROE of 348.4%. 3Y revenue CAGR of 29.8% highlights clear growth momentum.”

Ask for details →

Company Overview

Guardant Health Inc. is an innovative biotechnology company specializing in the development and commercialization of precision oncology diagnostics. This company is recognized for its groundbreaking work in non-invasive cancer detection through liquid biopsy technologies, which involve analyzing circulating tumor DNA in blood samples. Guardant Health’s primary function is to provide oncologists and researchers with critical tools and data to better understand cancer, tailor treatments, and monitor disease progression, potentially improving patient outcomes significantly. Guardant Health operates prominently in the healthcare and biotechnology sector, significantly impacting fields such as cancer research and personalized medicine. Their products and services are vital for facilitating early detection of cancer, identifying treatment options, and offering companion diagnostics for pharmaceutical developments. In the financial market, Guardant Health represents an important player within the precision medicine landscape, influencing investment within the biotechnology and healthcare sectors. Founded in 2012 and headquartered in Redwood City, California, the company continues to expand its portfolio and advance its technologies, playing a pivotal role in the fight against cancer at a global level.

CEODr. Helmy Eltoukhy Ph.D.

Websitehttps://guardanthealth.com

SectorHealthcare

IndustryDiagnostics & Research

Employees1,999

Company Statistics

FY 2025

Profile

$15.97BMarket Cap

$982.02MRevenue

0.00Shares Out

1,999Employees

Margins

64.46%Gross

-38.08%EBITDA

-44.53%Operating

-42.52%Pre-Tax

-42.39%Net

Valuation

-38.35P/E

-160.77P/B

16.26EV/Sales

-46.26EV/EBITDA

-68.50P/FCF

Growth (CAGR)

29.75%Rev 3Yr

27.92%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-23.79%ROA

348.42%ROE

-23.64%ROIC

Financial Health

$378.20MCash & Cash Equivalents

$1.73BNet Debt

-2127.71%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Guardant Health Inc. trades at a P/E of -38.4 (undervalued) with strong ROE of 348.4%. 3Y revenue CAGR of 29.8% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Guardant Health Inc. (ticker: GH) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 1,999 employees. Market cap is $16.0B.

The current price is $127.34 with a P/E ratio of -38.35x and P/B of -160.77x.

ROE is 348.42% and operating margin is -44.53%. Annual revenue is $982M.